An antibiotic derived from penicillin similar to CARBENICILLIN in action.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.
Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.
Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
A semisynthetic ampicillin-derived acylureido penicillin.
An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.
Substances that reduce the growth or reproduction of BACTERIA.
Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
Nonsusceptibility of an organism to the action of penicillins.
Infections with bacteria of the genus PSEUDOMONAS.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
A cephalosporin antibiotic.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.
A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed)
Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.
A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
Infections by bacteria, general or unspecified.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.
Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Infections with bacteria of the genus FUSOBACTERIUM.

Bacteriologic cure of experimental Pseudomonas keratitis. (1/168)

Two long-term therapy trials with high concentrations of antibiotic were carried out to determine the duration of therapy required to achieve bacteriologic cure of experimental Pseudomonas keratitis in guinea pigs. In the first study, corneas still contained Pseudomonas after 4 days of continual topical therapy with either tobramycin 400 mg/ml, amikacin 250 mg/ml, ticarcillin 400 mg/ml, or carbenicillin 400 mg/ml. In an 11-day trial of topical therapy with tobramycin 20 mg/ml, 34 of 36 corneas grew no Pseudomonas after 6 or more days of therapy. The bacteriologic response to therapy in this model occurred in two phases. About 99.9% or more of the organisms in the cornea were killed in the first 24 hr of therapy. The numbers of bacteria remaining in the cornea declined gradually over the next several days until the corneas were sterile. Optimal antibiotic therapy may include two stages: initial intensive therapy with high concentrations of antibiotic applied frequently to achieve a large rapid decrease in numbers of organisms in the cornea, followed by prolonged, less intensive therapy to eradicate organisms and prevent relapse.  (+info)

Case of sepsis caused by Bifidobacterium longum. (2/168)

We report a case of sepsis caused by Bifidobacterium longum in a 19-year-old male who had developed high fever, jaundice, and hepatomegaly after acupuncture therapy with small gold needles. Anaerobic, non-spore-forming, gram-positive bacilli were isolated from his blood and finally identified as B. longum. He recovered completely after treatment with ticarcillin and metronidazole. To our knowledge, this is the first report of incidental sepsis caused by B. longum.  (+info)

Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. (3/168)

Although previous studies have indicated that clavulanate may induce AmpC expression in isolates of Pseudomonas aeruginosa, the impact of this inducer activity on the antibacterial activity of ticarcillin at clinically relevant concentrations has not been investigated. Therefore, a study was designed to determine if the inducer activity of clavulanate was associated with in vitro antagonism of ticarcillin at pharmacokinetically relevant concentrations. By the disk approximation methodology, clavulanate induction of AmpC expression was observed with 8 of 10 clinical isolates of P. aeruginosa. Quantitative studies demonstrated a significant induction of AmpC when clavulanate-inducible strains were exposed to the peak concentrations of clavulanate achieved in human serum with the 3.2- and 3.1-g doses of ticarcillin-clavulanate. In studies with three clavulanate-inducible strains in an in vitro pharmacodynamic model, antagonism of the bactericidal effect of ticarcillin was observed in some tests with regimens simulating a 3.1-g dose of ticarcillin-clavulanate and in all tests with regimens simulating a 3.2-g dose of ticarcillin-clavulanate. No antagonism was observed in studies with two clavulanate-noninducible strains. In contrast to clavulanate. No antagonism was observed in studies with two clavulanate-noninducible strains. In contrast to clavulanate, tazobactam failed to induce AmpC expression in any strains, and the pharmacodynamics of piperacillin-tazobactam were somewhat enhanced over those of piperacillin alone against all strains studied. Overall, the data collected from the pharmacodynamic model suggested that induction per se was not always associated with reduced killing but that a certain minimal level of induction by clavulanate was required before antagonism of the antibacterial activity of its companion drug occurred. Nevertheless, since clinically relevant concentrations of clavulanate can antagonize the bactericidal activity of ticarcillin, the combination of ticarcillin-clavulanate should be avoided when selecting an antipseudomonal beta-lactam for the treatment of P. aeruginosa infections, particularly in immunocompromised patients. For piperacillin-tazobactam, induction is not an issue in the context of treating this pathogen.  (+info)

Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study. (4/168)

In a multicenter cooperative controlled study, individual test, accuracy, and precision control values were determined for 75-mug ticarcillin disks with Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.  (+info)

In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group. (5/168)

A total of 3903 pathogens from 48 Canadian medical centres were tested against 19 antimicrobial agents. Five agents showed activity against > or = 90% of all 1982 respiratory tract pathogens tested (ciprofloxacin, 90%; cefoperazone, 91%; ticarcillin/clavulanate, 92%; ceftazidime and imipenem, 93% each). Nine agents had > or = 90% activity against Enterobacteriaceae from respiratory tract infection (cefotaxime and ticarcillin/clavulanate, 90% each; aztreonam, ceftizoxime and ceftriaxone, 91% each; ceftazidime, 93%; ciprofloxacin, 97%; imipenem and netilmicin, 98% each). Similarly, five agents had activity against > or = 90% of all 1921 urinary tract pathogens tested (ciprofloxacin and ticarcillin/clavulanate, 90% each; cefoperazone and netilmicin, 91% each; imipenem, 99%). Nine agents had > or = 95% activity against Enterobacteriaceae from urinary tract infection (ciprofloxacin, 95%; cefotetan, 97%; aztreonam, cefotaxime, ceftazidime, ceftizoxime, ceftriaxone and netilmicin, 98% each; imipenem, 99%). Seventeen agents had activity against > or = 95% of Staphylococcus aureus strains. Susceptibility of Pseudomonas aeruginosa isolates ranged from 2% to 91%.  (+info)

Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. (6/168)

Sodium piperacillin T-1220, a new semisynthetic penicillin, was tested in vitro against 297 clinical isolates of anaerobic bacteria and 669 aerobic bacteria by the conventional agar dilution method and compared with carbenicillin and ticarcillin. At a 100-mug/ml concentration the three drugs showed comparable effectiveness against the anaerobes tested. However, at 20 mug/ml, piperacillin was the most effective drug against Bacteroides fragilis, peptostreptococci, and group D streptococci. At this drug concentration only 48% of the B. fragilis strains exhibited susceptibility to carbenicillin only, 64% exhibited susceptibility to ticarcillin but 90% exhibited susceptibility to piperacillin. Similar findings were observed with peptostreptococci and group D streptococci. On a weight basis piperacillin was statistically shown to be the most effective antibiotic of the three tested against these anaerobes. At 20 mug/ml, piperacillin exhibited a statistically significant difference (P < 0.01) over carbenicillin and ticarcillin for Serratia marcescens, Escherichia coli, Klebsiella species, Klebsiella pneumoniae, Pseudomonas isolates, and Citrobacter diversus. At both 20- and 100-mug/ml concentrations, piperacillin appeared to be the most effective (calculated P < 0.01) upon Klebsiella species, K. pneumoniae, S. marcescens, and C. freundii in activity over ticarcillin and carbenicillin.  (+info)

Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents. (7/168)

Cancer chemotherapeutic agents and antibacterial antibiotics are often given concomitantly. Daunorubicin, cytosine arabinoside, and three antibiotics (gentamicin, amikacin, and ticarcillin) were tested individually and in combinations to determine their antimicrobial activity against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. These cytotoxic agents are commonly employed in the therapy of acute nonlymphocytic leukemia for remission induction therapy, and these antimicrobial agents are used in infection therapy. The maximum concentrations of the two cytotoxic drugs were chosen to be twice the known peak plasma levels of commonly employed dosage schedules. Neither of the cancer chemotherapeutic agents, alone or in combination, demonstrated bactericidal activity at the levels tested. However, in the presence of these agents, the antimicrobial activity of gentamicin and amikacin, although not that of ticarcillin, was depressed for 11 of 15 K. pneumoniae strains and 8 of 15 P. aeruginosa strains, but for none of the strains of E. coli. This level of decreased activity occasionally resulted in a minimal inhibitory concentration of the tested aminoglycoside well above the standard serum levels. Daunorubicin was more likely to antagonize gentamicin than was cytosine arabinoside.  (+info)

In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. (8/168)

The in-vitro activities of imipenem and four beta-lactam-beta-lactamase inhibitor combinations were tested against 816 strains of the Bacteroides fragilis group, and compared with other anti-anaerobic agents. None of the strains was resistant to metronidazole, and only one was resistant to chloramphenicol. Mezlocillin and piperacillin were moderately active, while clindamycin was the least active. Rates of resistance varied between various species. The new beta-lactam agents tested showed excellent activity; piperacillin-tazobactam and imipenem were the most active. The emergence of strains that are resistant to these agents, observed in this study, suggests there is a need to perform periodic antimicrobial susceptibility tests.  (+info)

Ticarcillin is an antibiotic medication that belongs to the class of drugs called penicillins. It is primarily used to treat infections caused by susceptible bacteria. Ticarcillin has activity against various gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa.

The drug works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death. It is often administered intravenously in a hospital setting due to its poor oral bioavailability. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions, including rash and itching.

It's important to note that the use of ticarcillin should be based on the results of bacterial culture and sensitivity testing to ensure its effectiveness against the specific bacteria causing the infection. Additionally, healthcare providers should monitor renal function during treatment, as ticarcillin can affect kidney function in some patients.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to

Clavulanic acid is not a medical condition, but rather an antibacterial compound that is often combined with certain antibiotics to increase their effectiveness against bacteria that have become resistant to the antibiotic alone. It works by inhibiting certain enzymes produced by bacteria that help them to resist the antibiotic, allowing the antibiotic to work more effectively.

Clavulanic acid is typically combined with antibiotics such as amoxicillin or ticarcillin to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is important to note that clavulanate-containing medications should only be used under the direction of a healthcare provider, as misuse or overuse can contribute to antibiotic resistance.

Clavulanic acid is a type of beta-lactamase inhibitor, which is a compound that is used to increase the effectiveness of certain antibiotics. It works by preventing the breakdown of beta-lactam antibiotics (such as penicillins and cephalosporins) by bacterial enzymes called beta-lactamases. This allows the antibiotic to remain active against the bacteria for a longer period of time, increasing its ability to kill the bacteria and treat the infection.

Clavulanic acid is often combined with amoxicillin in a medication called Augmentin, which is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It may also be used in other combinations with other beta-lactam antibiotics.

Like all medications, clavulanic acid can have side effects, including gastrointestinal symptoms such as diarrhea, nausea, and vomiting. It may also cause allergic reactions in some people, particularly those who are allergic to penicillin or other beta-lactam antibiotics. It is important to follow the instructions of a healthcare provider when taking clavulanic acid or any medication.

Azlocillin is a semisynthetic antibiotic belonging to the class of extended-spectrum penicillins. It is derived from the basic penicillin structure and has an additional side chain that provides it with a broader spectrum of activity, including against many Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa.

Azlocillin works by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. It is commonly used in the treatment of severe intra-abdominal infections, urinary tract infections, and septicemia caused by susceptible organisms.

Like other antibiotics, azlocillin should be used with caution and only when necessary, as overuse can lead to the development of antibiotic resistance. It is important to note that individual patient responses to medications may vary, and healthcare providers should consider each patient's unique medical history and current health status before prescribing any medication.

Tobramycin is an aminoglycoside antibiotic used to treat various types of bacterial infections. According to the Medical Subject Headings (MeSH) terminology of the National Library of Medicine (NLM), the medical definition of Tobramycin is:

"A semi-synthetic modification of the aminoglycoside antibiotic, NEOMYCIN, that retains its antimicrobial activity but has less nephrotoxic and neurotoxic side effects. Tobramycin is used in the treatment of serious gram-negative infections, especially Pseudomonas infections in patients with cystic fibrosis."

Tobramycin works by binding to the 30S ribosomal subunit of bacterial cells, inhibiting protein synthesis and ultimately leading to bacterial cell death. It is commonly used to treat severe infections caused by susceptible strains of gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Serratia marcescens, and Enterobacter species.

Tobramycin is available in various formulations, such as injectable solutions, ophthalmic ointments, and inhaled powder for nebulization. The choice of formulation depends on the type and location of the infection being treated. As with any antibiotic, it's essential to use Tobramycin appropriately and under medical supervision to minimize the risk of antibiotic resistance and potential side effects.

Piperacillin is a type of antibiotic known as a semisynthetic penicillin that is used to treat a variety of infections caused by bacteria. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die.

Piperacillin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics. It is often used in combination with other antibiotics, such as tazobactam, to increase its effectiveness against certain types of bacteria.

Piperacillin is typically administered intravenously in a hospital setting and is used to treat serious infections such as pneumonia, sepsis, and abdominal or urinary tract infections. As with all antibiotics, it should be used only when necessary and under the guidance of a healthcare professional to reduce the risk of antibiotic resistance.

Mezlocillin is a type of antibiotic known as a semisynthetic penicillin, which is derived from the Penicillium fungus. It is primarily used to treat infections caused by susceptible Gram-negative bacteria, such as Escherichia coli (E. coli), Klebsiella pneumoniae, and Proteus mirabilis. Mezlocillin works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death.

Mezlocillin is often administered intravenously in a hospital setting due to its poor oral bioavailability. It is typically used in combination with other antibiotics, such as an aminoglycoside, to broaden the spectrum of activity and reduce the risk of bacterial resistance.

Common side effects of mezlocillin include diarrhea, nausea, vomiting, and skin rashes. More serious side effects can include allergic reactions, kidney damage, and hearing loss. Mezlocillin should be used with caution in patients with a history of penicillin allergy or impaired kidney function.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Amikacin is a type of antibiotic known as an aminoglycoside, which is used to treat various bacterial infections. It works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. Amikacin is often used to treat serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It may be given intravenously or intramuscularly, depending on the severity and location of the infection. As with all antibiotics, amikacin should be used judiciously to prevent the development of antibiotic resistance.

Enterobacteriaceae is a family of gram-negative, rod-shaped bacteria that are commonly found in the intestines of humans and animals. Many species within this family are capable of causing various types of infections, particularly in individuals with weakened immune systems. Some common examples of Enterobacteriaceae include Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis, and Salmonella enterica.

These bacteria are typically characterized by their ability to ferment various sugars and produce acid and gas as byproducts. They can also be distinguished by their biochemical reactions, such as their ability to produce certain enzymes or resist specific antibiotics. Infections caused by Enterobacteriaceae can range from mild to severe, depending on the species involved and the overall health of the infected individual.

Some infections caused by Enterobacteriaceae include urinary tract infections, pneumonia, bloodstream infections, and foodborne illnesses. Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of these bacteria and reduce the risk of infection.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Moxalactam is not a medical condition but actually an antibiotic medication. It is a type of beta-lactam antibiotic, specifically a fourth-generation cephalosporin, which is used to treat various bacterial infections. Moxalactam has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many that are resistant to other antibiotics.

Moxalactam works by inhibiting the synthesis of the bacterial cell wall, leading to bacterial death. It is commonly used to treat intra-abdominal infections, urinary tract infections, pneumonia, and sepsis, among other conditions. As with any medication, moxalactam can have side effects, including gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions and changes in liver function tests. It is important to use antibiotics only when necessary and under the guidance of a healthcare professional to minimize the development of antibiotic resistance.

Penicillanic acid is not a term that has a widely accepted or established medical definition in the context of human medicine or clinical practice. It is a chemical compound that is a derivative of penicillin, an antibiotic produced by certain types of mold. Penicillanic acid is a breakdown product of penicillin and is not itself used as a medication.

In chemistry, penicillanic acid is a organic compound with the formula (CH3)2C6H5COOH. It is a derivative of benzene and has a carboxylic acid group and a five-membered ring containing a sulfur atom and a double bond, which is a characteristic feature of penicillin and its derivatives.

It's important to note that while penicillanic acid may have relevance in the context of chemistry or microbiology research, it does not have a direct medical definition or application in clinical medicine.

Cefoxitin is a type of antibiotic known as a cephamycin, which is a subclass of the larger group of antibiotics called cephalosporins. Cephalosporins are bactericidal agents that inhibit bacterial cell wall synthesis by binding to and disrupting the function of penicillin-binding proteins (PBPs).

Cefoxitin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many strains that are resistant to other antibiotics. It is commonly used to treat infections caused by susceptible organisms such as:

* Staphylococcus aureus (including methicillin-resistant S. aureus or MRSA)
* Streptococcus pneumoniae
* Escherichia coli
* Klebsiella spp.
* Proteus mirabilis
* Bacteroides fragilis and other anaerobic bacteria

Cefoxitin is available in both intravenous (IV) and intramuscular (IM) formulations, and it is typically administered every 6 to 8 hours. The drug is generally well tolerated, but potential side effects include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, as well as allergic reactions, including rash, pruritus, and anaphylaxis.

It's important to note that the use of antibiotics should be based on the results of bacterial cultures and susceptibility testing whenever possible, to ensure appropriate therapy and minimize the development of antibiotic resistance.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

Gentamicin is an antibiotic that belongs to the class of aminoglycosides. It is used to treat various types of bacterial infections, including:

* Gram-negative bacterial infections, such as those caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis
* Certain Gram-positive bacterial infections, such as those caused by Staphylococcus aureus and Streptococcus pyogenes

Gentamicin works by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death. It is typically given via injection (intramuscularly or intravenously) and is often used in combination with other antibiotics to treat serious infections.

Like all aminoglycosides, gentamicin can cause kidney damage and hearing loss, especially when used for long periods of time or at high doses. Therefore, monitoring of drug levels and renal function is recommended during treatment.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

Cefsulodin is a type of antibiotic known as a cephalosporin, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. By damaging the cell wall, Cefsulodin causes the bacterium to become unstable and eventually die.

Cefsulodin is a broad-spectrum antibiotic, which means it is effective against a wide range of bacteria. It is often used to treat infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa, which can be difficult to treat with other types of antibiotics.

Cefsulodin is usually given by injection into a vein (intravenously) or muscle (intramuscularly). It may also be given as a topical solution for skin infections. As with all antibiotics, Cefsulodin should only be used under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished.

Like other cephalosporins, Cefsulodin can cause side effects such as diarrhea, nausea, vomiting, and rash. In rare cases, it may also cause serious side effects such as an allergic reaction, kidney damage, or seizures. It is important to inform your healthcare provider of any medical conditions you have and any medications you are taking before starting treatment with Cefsulodin.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Pseudomonas infections are infections caused by the bacterium Pseudomonas aeruginosa or other species of the Pseudomonas genus. These bacteria are gram-negative, opportunistic pathogens that can cause various types of infections, including respiratory, urinary tract, gastrointestinal, dermatological, and bloodstream infections.

Pseudomonas aeruginosa is a common cause of healthcare-associated infections, particularly in patients with weakened immune systems, chronic lung diseases, or those who are hospitalized for extended periods. The bacteria can also infect wounds, burns, and medical devices such as catheters and ventilators.

Pseudomonas infections can be difficult to treat due to the bacteria's resistance to many antibiotics. Treatment typically involves the use of multiple antibiotics that are effective against Pseudomonas aeruginosa. In severe cases, intravenous antibiotics or even hospitalization may be necessary.

Prevention measures include good hand hygiene, contact precautions for patients with known Pseudomonas infections, and proper cleaning and maintenance of medical equipment.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

Cefamandole is a second-generation cephalosporin antibiotic, which is a type of antibacterial medication used to treat various infections caused by bacteria. It works by interfering with the ability of bacteria to form cell walls, resulting in weakening and eventual death of the bacterial cells.

Cefamandole has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making it useful for treating a variety of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Like other cephalosporins, cefamandole is generally well-tolerated and has a low incidence of serious side effects. However, it can cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions in some people. It may also interact with other medications, so it's important to inform your healthcare provider of all the medications you are taking before starting cefamandole therapy.

It is important to note that antibiotics should only be used to treat bacterial infections and not viral infections, as they are not effective against viruses and can contribute to the development of antibiotic resistance.

Cephalothin is a type of antibiotic known as a first-generation cephalosporin. It is used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, and urinary tract infections.

Cephalothin works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. It binds to specific proteins in the bacterial cell wall, causing the wall to become unstable and ultimately leading to the death of the bacterium.

Like other antibiotics, cephalothin is only effective against certain types of bacteria, and it should be used under the direction of a healthcare professional. It is important to take the full course of treatment as directed, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of developing antibiotic resistance.

Common side effects of cephalothin include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. More serious side effects may include allergic reactions, kidney damage, and seizures. It is important to inform your healthcare provider of any medical conditions you have or medications you are taking before starting treatment with cephalothin.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Kanamycin is an aminoglycoside antibiotic that is derived from the bacterium Streptomyces kanamyceticus. It works by binding to the 30S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to bacterial cell death. Kanamycin is primarily used to treat serious infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It is also used in veterinary medicine to prevent bacterial infections in animals.

Like other aminoglycosides, kanamycin can cause ototoxicity (hearing loss) and nephrotoxicity (kidney damage) with prolonged use or high doses. Therefore, it is important to monitor patients closely for signs of toxicity and adjust the dose accordingly. Kanamycin is not commonly used as a first-line antibiotic due to its potential side effects and the availability of safer alternatives. However, it remains an important option for treating multidrug-resistant bacterial infections.

Cloxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Cloxacillin works by interfering with the ability of the bacterial cell wall to grow and multiply, ultimately leading to the death of the bacterium.

Cloxacillin is often used to treat skin infections, pneumonia, and other respiratory tract infections. It is available in various forms, including tablets, capsules, and powder for injection. As with all antibiotics, it is important to take cloxacillin exactly as directed by a healthcare provider, and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Like other penicillins, cloxacillin can cause allergic reactions in some people. It may also interact with other medications, so it is important to inform a healthcare provider of all other medications being taken before starting cloxacillin.

Aztreonam is a monobactam antibiotic, which is a type of antibacterial drug used to treat infections caused by bacteria. It works by interfering with the ability of bacterial cells to form cell walls, leading to their death. Aztreonam is specifically active against certain types of gram-negative bacteria, including Pseudomonas aeruginosa and Escherichia coli.

Aztreonam is available in various forms, including injectable solutions and inhaled powder, for use in different clinical settings. It is often used to treat serious infections that have not responded to other antibiotics or that are caused by bacteria that are resistant to other antibiotics.

Like all antibiotics, aztreonam can cause side effects, including nausea, vomiting, diarrhea, and headache. It may also cause allergic reactions in some people, particularly those with a history of allergies to other antibiotics. It is important to use aztreonam only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

Cephamycins are a subclass of cephalosporin antibiotics, which are derived from the fungus Acremonium species. They have a similar chemical structure to other cephalosporins but have an additional methoxy group on their side chain that makes them more resistant to beta-lactamases, enzymes produced by some bacteria that can inactivate other cephalosporins and penicillins.

Cephamycins are primarily used to treat infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Proteus species, and Enterobacter species. They have a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making them useful for treating a variety of infections.

The two main cephamycins that are used clinically are cefoxitin and cefotetan. Cefoxitin is often used to treat intra-abdominal infections, pelvic inflammatory disease, and skin and soft tissue infections. Cefotetan is primarily used for the treatment of surgical prophylaxis, gynecological infections, and pneumonia.

Like other cephalosporins, cephamycins can cause allergic reactions, including rashes, hives, and anaphylaxis. They should be used with caution in patients who have a history of allergies to penicillin or other beta-lactam antibiotics. Additionally, cephamycins can disrupt the normal gut flora, leading to secondary infections such as Clostridioides difficile (C. diff) diarrhea.

Imipenem is an antibiotic medication that belongs to the class of carbapenems. It is used to treat various types of bacterial infections, including pneumonia, sepsis, and skin infections. Imipenem works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death.

Imipenem is often combined with another medication called cilastatin, which helps to prevent the breakdown of imipenem in the body and increase its effectiveness. The combination of imipenem and cilastatin is available under the brand name Primaxin.

Like other antibiotics, imipenem should be used with caution and only when necessary, as overuse can lead to antibiotic resistance. It is important to follow the prescribing physician's instructions carefully and complete the full course of treatment, even if symptoms improve before the medication is finished.

Drug incompatibility refers to a situation where two or more drugs cannot be mixed, combined, or administered together because they will interact in a way that reduces their effectiveness, causes unintended side effects, or even results in harm to the patient. This can occur due to chemical reactions between the drugs, physical interactions (such as precipitation), or pharmacological interactions (such as one drug inhibiting the metabolism of another).

Drug incompatibilities can be identified through various methods, including laboratory testing, literature review, and clinical experience. Healthcare professionals must be aware of potential drug incompatibilities and take steps to avoid them when prescribing or administering medications to patients. This may involve using different administration routes, changing the timing of medication administration, or selecting alternative drugs that are compatible with each other.

Netilmicin is an aminoglycoside antibiotic, which is used to treat various types of bacterial infections. According to the medical definition, Netilmicin is a sterile, pyrogen-free, pale yellow to light brown, clear solution, available for intramuscular and intravenous administration. It is a semisynthetic antibiotic derived from sisomicin that is used against severe infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

The mechanism of action for Netilmicin involves binding to the 30S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and causing bacterial cell death. Similar to other aminoglycosides, Netilmicin is not absorbed from the gastrointestinal tract and is excreted unchanged by glomerular filtration in the kidneys.

It's important to note that Netilmicin can cause nephrotoxicity (kidney damage) and ototoxicity (hearing loss or balance problems), so it should be used with caution, particularly in patients with pre-existing renal impairment or hearing issues. Regular monitoring of renal function and auditory function is recommended during treatment with Netilmicin.

Gram-negative aerobic bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, which is a technique used to differentiate bacterial species based on their cell wall composition. These bacteria have a thin peptidoglycan layer and an outer membrane containing lipopolysaccharides (LPS), making them resistant to many antibiotics and disinfectants. They are called aerobic because they require oxygen for their growth and metabolism. Examples of Gram-negative aerobic bacteria include Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. These bacteria can cause various infections in humans, such as pneumonia, urinary tract infections, and sepsis.

A drug combination refers to the use of two or more drugs in combination for the treatment of a single medical condition or disease. The rationale behind using drug combinations is to achieve a therapeutic effect that is superior to that obtained with any single agent alone, through various mechanisms such as:

* Complementary modes of action: When different drugs target different aspects of the disease process, their combined effects may be greater than either drug used alone.
* Synergistic interactions: In some cases, the combination of two or more drugs can result in a greater-than-additive effect, where the total response is greater than the sum of the individual responses to each drug.
* Antagonism of adverse effects: Sometimes, the use of one drug can mitigate the side effects of another, allowing for higher doses or longer durations of therapy.

Examples of drug combinations include:

* Highly active antiretroviral therapy (HAART) for HIV infection, which typically involves a combination of three or more antiretroviral drugs to suppress viral replication and prevent the development of drug resistance.
* Chemotherapy regimens for cancer treatment, where combinations of cytotoxic agents are used to target different stages of the cell cycle and increase the likelihood of tumor cell death.
* Fixed-dose combination products, such as those used in the treatment of hypertension or type 2 diabetes, which combine two or more active ingredients into a single formulation for ease of administration and improved adherence to therapy.

However, it's important to note that drug combinations can also increase the risk of adverse effects, drug-drug interactions, and medication errors. Therefore, careful consideration should be given to the selection of appropriate drugs, dosing regimens, and monitoring parameters when using drug combinations in clinical practice.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

Aminoglycosides are a class of antibiotics that are derived from bacteria and are used to treat various types of infections caused by gram-negative and some gram-positive bacteria. These antibiotics work by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death.

Some examples of aminoglycosides include gentamicin, tobramycin, neomycin, and streptomycin. These antibiotics are often used in combination with other antibiotics to treat severe infections, such as sepsis, pneumonia, and urinary tract infections.

Aminoglycosides can have serious side effects, including kidney damage and hearing loss, so they are typically reserved for use in serious infections that cannot be treated with other antibiotics. They are also used topically to treat skin infections and prevent wound infections after surgery.

It's important to note that aminoglycosides should only be used under the supervision of a healthcare professional, as improper use can lead to antibiotic resistance and further health complications.

Carboxylic acids are organic compounds that contain a carboxyl group, which is a functional group made up of a carbon atom doubly bonded to an oxygen atom and single bonded to a hydroxyl group. The general formula for a carboxylic acid is R-COOH, where R represents the rest of the molecule.

Carboxylic acids can be found in various natural sources such as in fruits, vegetables, and animal products. Some common examples of carboxylic acids include formic acid (HCOOH), acetic acid (CH3COOH), propionic acid (C2H5COOH), and butyric acid (C3H7COOH).

Carboxylic acids have a variety of uses in industry, including as food additives, pharmaceuticals, and industrial chemicals. They are also important intermediates in the synthesis of other organic compounds. In the body, carboxylic acids play important roles in metabolism and energy production.

Ceftazidime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Ceftazidime has a broad spectrum of activity and is effective against many Gram-negative and some Gram-positive bacteria.

It is often used to treat serious infections such as pneumonia, urinary tract infections, and sepsis, particularly when they are caused by antibiotic-resistant bacteria. Ceftazidime is also commonly used in combination with other antibiotics to treat complicated abdominal infections, bone and joint infections, and hospital-acquired pneumonia.

Like all antibiotics, ceftazidime can cause side effects, including diarrhea, nausea, vomiting, and allergic reactions. It may also affect the kidneys and should be used with caution in patients with impaired renal function. Ceftazidime is available in both intravenous (IV) and oral forms.

Klebsiella is a genus of Gram-negative, facultatively anaerobic, encapsulated, non-motile, rod-shaped bacteria that are part of the family Enterobacteriaceae. They are commonly found in the normal microbiota of the mouth, skin, and intestines, but can also cause various types of infections, particularly in individuals with weakened immune systems.

Klebsiella pneumoniae is the most common species and can cause pneumonia, urinary tract infections, bloodstream infections, and wound infections. Other Klebsiella species, such as K. oxytoca, can also cause similar types of infections. These bacteria are resistant to many antibiotics, making them difficult to treat and a significant public health concern.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Fusobacterium infections are diseases or conditions caused by the bacterial genus Fusobacterium, which are gram-negative, anaerobic bacilli. These bacteria are commonly found as normal flora in the oral cavity, gastrointestinal tract, and female genital tract. However, under certain circumstances, they can cause infections, particularly in individuals with weakened immune systems or underlying medical conditions.

Fusobacterium infections can manifest in various forms, including:

1. Oral infections: Fusobacterium nucleatum is the most common species associated with oral infections, such as periodontitis, abscesses, and Ludwig's angina.
2. Respiratory tract infections: Fusobacterium necrophorum can cause lung abscesses, empyema, and bronchitis.
3. Bloodstream infections (bacteremia): Fusobacterium species can enter the bloodstream through various routes, such as dental procedures or invasive medical procedures, leading to bacteremia. This condition can be particularly dangerous for individuals with compromised immune systems or underlying medical conditions.
4. Intra-abdominal infections: Fusobacterium species can cause intra-abdominal abscesses, peritonitis, and appendicitis.
5. Skin and soft tissue infections: Fusobacterium species can cause cellulitis, myositis, and necrotizing fasciitis.
6. Bone and joint infections: Fusobacterium species can cause osteomyelitis and septic arthritis.
7. Central nervous system infections: Fusobacterium species can cause meningitis and brain abscesses, although these are rare.

Fusobacterium infections can be challenging to treat due to their anaerobic nature and resistance to certain antibiotics. Therefore, it is essential to seek medical attention if you suspect a Fusobacterium infection. Treatment typically involves the use of appropriate antibiotics, such as metronidazole or clindamycin, and sometimes surgical intervention may be necessary.

... is a carboxypenicillin. It can be sold and used in combination with clavulanate as ticarcillin/clavulanic acid. ... Ticarcillin is not absorbed orally, so must be given by intravenous or intramuscular injection. Ticarcillin: Ticar was formerly ... Ticarcillin is also often paired with a β-lactamase inhibitor such as clavulanic acid (co-ticarclav).[citation needed] In ... Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis ...
... and ticarcillin/clavulanate. Carbapenems are also an option when treating primary peritonitis as all of the carbapenems cover ...
P. vulgaris is not sensitive to these antibiotics but ticarcillin. However, this organism is isolated less often in the ...
Therapies include treatment with penicillin, sulfadimethoxine, flucloxacillin, clindamycin, tetracycline, and ticarcillin. A. ...
This bacterium is susceptible to the β-lactam antibiotics imipenem, cefoxitin, and ticarcillin. B. wadsworthia is a Gram- ...
They belong to the penicillin family and comprise the members carbenicillin and ticarcillin. The carboxypenicillins feature the ...
Many strains of S. maltophilia are sensitive to co-trimoxazole and ticarcillin, though resistance has been increasing. It is ...
Ticarcillin (often used in combination with clavulanic acid under the designation Timentin), amikacin sulfate, penicillin, and ...
... ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.[ ...
Another development of the line of penicillins was the antipseudomonal penicillins, such as carbenicillin, ticarcillin, and ...
Carbenicillin Ticarcillin Temocillin Mezlocillin Piperacillin Azlocillin Clavulanic acid Sulbactam Tazobactam The term " ... Another development of the line of true penicillins was the antipseudomonal penicillins, such as carbenicillin, ticarcillin, ...
Ureidopenicillins Azlocillin Mezlocillin Piperacillin Carboxypenicillins Ticarcillin (generally in the combination ticarcillin/ ...
This may consist of a broad spectrum antibiotic; such as piperacillin-tazobactam, ampicillin-sulbactam, ticarcillin-clavulanate ...
Piperacillin and Piperacillin/tazobactam Ticarcillin/clavulanic acid Certain carbapenems and carbapenem-beta-lactamase- ...
... ticarcillin MeSH D03.438.449.130 - benzydamine MeSH D03.438.449.350 - granisetron MeSH D03.438.473.025 - adrenochrome MeSH ... ticarcillin MeSH D03.605.084.750 - ramipril MeSH D03.605.168.350 - ethylketocyclazocine MeSH D03.605.497.150 - buprenorphine ...
... ticarcillin) these drugs may be combined with beta-lactamase inhibitors to combat the presence of enzymes that can digest these ...
... ticarcillin, amphotericin B, corticosteroids, and excessive laxative use. Amiodarone, some benzodiazepines, cyclosporine, ...
... carbenicillin and ticarcillin), and ureidopenicillins (mezlocillin, azlocillin, and piperacillin). P. aeruginosa is ...
Intrapartum antibiotic treatment consists of: Standard Ampicillin + gentamicin Alternative Ampicillin/sulbactam Ticarcillin/ ...
Treatment of M. morganii infections may include:[citation needed] Ticarcillin Piperacillin Ciprofloxacin Third-generation and ...
... ticarcillin (co-ticarclav, trade name Timentin) Clavulanic acid was patented in 1974. Amoxicillin-clavulanic acid is a first- ...
Oxacillin Temocillin Amoxicillin Ampicillin Mecillinam Piperacillin Carbenicillin Ticarcillin Carbenicillin Ticarcillin ...
... ticarcillin MeSH D02.065.589.200 - caprolactam MeSH D02.065.589.327 - lactams, macrocyclic MeSH D02.065.793.650 - ...
Chloramphenicol Ticarcillin Trimethoprim/sulfamethoxazole (Bactrim) Ofloxacin In veterinary medicine, co-amoxiclav, (in small ...
... ticarcillin) Timentin (ticarcillin/clavulanate) Pharmaceutical industry in the United Kingdom "Get powerful relief from cold & ...
... ticarcillin-clavulanate (co-ticarclav), and ampicillin/sulbactam, they normally remain susceptible to inhibition by tazobactam ... ticarcillin-clavulanate, and ampicillin/sulbactam, they remain susceptible to inhibition by tazobactam and subsequently the ...
Empirical coverage should consist of either a penicillin with a B-lactamase inhibitor such as amoxicillin/ticarcillin with ...
... ticarcillin-clavulanate, mupirocin, and ceftazidime for bacterial infections, zidovudine for HIV infection, valacyclovir for ...
... vancomycin/linezolid and ceftazidime Ureidopenicillin plus β-lactamase inhibitor such as piperacillin/tazobactam or ticarcillin ...
... when combined with ticarcillin, in people with cancer Intra-abdominal infections (such as peritonitis) as an adjunct to other ...
Ticarcillin is a carboxypenicillin. It can be sold and used in combination with clavulanate as ticarcillin/clavulanic acid. ... Ticarcillin is not absorbed orally, so must be given by intravenous or intramuscular injection. Ticarcillin: Ticar was formerly ... Ticarcillin is also often paired with a β-lactamase inhibitor such as clavulanic acid (co-ticarclav).[citation needed] In ... Ticarcillins antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis ...
Ticarcillin/Ticar. Ticarcillin/Ticar. - See:. - Timentin. - Pen Family. - AntiPseudo. - There are small differences in the ... Ticarcillin is two to four times more active than carbenicillin against P. aeruginosa;. - less active against gram positive ...
The ready-to-use Timentin Ticarcillin solution has a broader spectrum and primarily works against gram-negative bacteria. ... Timentin™ is a 15:1 mixture of ticarcillin and clavulanate. Ticarcillin is a penicillin ß-lactam antibiotic, which is ... Ticarcillin Disodium/Potassium Clavulanate in H2O. (100 mg/mL Premade Solution, 0.2 µm Sterile Filtered). ... Safety Data Sheet - Timentin™ Ticarcillin/Clavulanate (15/1) 100 mg/mL Solution ...
Plot -6, Savitri Market, Block C1, Janakpuri, New Delhi - 110058, India. ...
Sinusitis is characterized by inflammation of the lining of the paranasal sinuses. Because the nasal mucosa is simultaneously involved and because sinusitis rarely occurs without concurrent rhinitis, rhinosinusitis is now the preferred term for this condition.
Ticarcillin. ,256. ,256. ,256. 2. Ticarcillin + CLA. ,256. 32. 128. 2. Piperacillin. ,256. ,256. 64. 1. ...
Detailed drug Information for Ortho-Cyclen. Includes common brand names, drug descriptions, warnings, side effects and dosing information.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.. Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.. ...
Acyclovir reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).
Ticarcillin/ Clavulanate (n †=24) * Number of patients with laboratory adverse experiences/Number of patients with the ... Ticarcillin/ Clavulanate † (N=24) * Includes Phase IIb Complicated skin and skin structure infections, Community acquired ... to ticarcillin/clavulanate (50 mg/kg for patients ,60 kg or 3.0 g for patients ,60 kg, 4 or 6 times a day) up to 14 days for ... 60 kg or ticarcillin/clavulanate 3.0 g for patients ,60 kg, 4 or 6 times a day.. ...
Ticarcillin And Clavulanate (Intravenous Route) * Tice BCG - Tice BCG, also known asBacillus Of Calmette And Guerin Vaccine, ... Timentin - Timentin, also known asTicarcillin And Clavulanate (Intravenous Route) * Timentin Novaplus - Timentin Novaplus, also ... known asTicarcillin And Clavulanate (Intravenous Route) * Timolide - Timolide, also known asTimolol And Hydrochlorothiazide ( ...
Ticarcillin-clavulanate 3.1 g IV q4hr Newer agents for gram-positive organisms [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 ...
Ticarcillin + Clavulanate. Dosing. *Usual Dosage: 3.1 g q6h. *CrCl 30 - 49 mL/min: 3.1 g q6h ...
Ticarcillin. 55. 43. 47. 23. 20. 0. 91. 67. 35. 57. 44. 39. 71. 50. 71. 50. 64. 21. 0. 0. 0. 0. 36. 39. 25. 0. 17. 0. 60. 100. ...
Ticarcillin Disodium and Clavulanate. Potassium. Tisagenlecleucel. Trabectedin. Trace Metals. Treprostinil. Vaccinia Immune ...
Ticarcillin/clavulanate 3.1 g q 4-6 h or cefoxitin 2 g iv. q 6 h or ertapenem 1 g iv. q 24 h or moxifloxacin 400 mg iv. q 24 h‡ ...
Clavulanate-ticarcillin*#. 15-40 mg/kg IV q 8 h; reconstituted injectable sol. 0.15-0.3 m/ear q 12 h; 160 mg/ml sol. 0.15-0.3 ... Ticarcillin, polymyxin B, neomycin, tobramycin and amikacin are potentially ototoxic. Neomycin can cause contact reactions. ... Solutions of 0.6% enrofloxacin, 0.2% marbofloxacin, 0.3% gentamicin, 0.1% amikacin, 2.8% ticarcillin and 1.7% ceftazidime in ...
Other members of this class include ampicillin (Unasyn), piperacillin (Pipracil), ticarcillin (Ticar), and others. These ...
ticarcillin. ticarcillin decreases effects of tobramycin by altering metabolism. Minor/Significance Unknown. Increased risk in ... ticarcillin. Minor (1)ticarcillin decreases effects of tobramycin by altering metabolism. Minor/Significance Unknown. Increased ...
Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the US and Canada) is dedicated to using leading-edge science to save and improve lives around the world. The Veterinary Manual was first published in 1955 as a service to the community. The legacy of this great resource continues in the online and mobile app versions today.. ...
ticarcillin. Monitor Closely (1)ticarcillin, cephalexin. Either increases levels of the other by decreasing renal clearance. ... ticarcillin. ticarcillin, cephalexin. Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor. ...
ticarcillin. Serious - Use Alternative (1)ticarcillin, probenecid. Either increases levels of the other by decreasing renal ... ticarcillin. ticarcillin, probenecid. Either increases levels of the other by decreasing renal clearance. Avoid or Use ...
Tobi - Get up-to-date information on Tobi side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Tobi
Ticarcillin-Clavulanate. When taken with amoxicillin, bromelain was shown to increase absorption of amoxicillin in humans. When ...
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile ...
Ticarcillin, symptoms of low blood pressure can include. Cialis, erythromycin lactobionate, if this happens, serum testosterone ...
However, both dogs in cohort 1 received antimicrobial treatment (metronidazole, ticarcillin-clavulanate, and amoxicillin- ... ticarcillin-clavulanate, or amoxicillin-clavulanate) administration for fever, increased IV administration of crystalloid ...
  • Other members of this class include ampicillin (Unasyn), piperacillin (Pipracil), ticarcillin (Ticar), and others. (medicinenet.com)
  • 81% of P. aeruginosa isolateswere sensitive to piperacillin/tazobactam and ticarcillin, while 60% were resistant to third generation of cephalosporins. (magiran.com)
  • Susceptibility to ceftazidime, ticarcillin, imipenem, and piperacillin/tazobactam were higher among isolates obtained from non-ICU patients. (magiran.com)
  • As an alternative, newer agents such as cefotetan, ampicillin-sulbactam, ticarcillin with or without clavulanic acid, piperacillin with or without tazobactam and ceftizoxime provide good coverage and can be continued following cesarean delivery. (aafp.org)
  • Azlocillin and mezlocillin are no longer on the market, having been replaced in clinical practice by ticarcillin-clavulanate and piperacillin-tazobactam, and are not discussed further. (rwmansiononpeachtree.com)
  • It can be sold and used in combination with clavulanate as ticarcillin/clavulanic acid. (wikipedia.org)
  • Ticarcillin is also often paired with a β-lactamase inhibitor such as clavulanic acid (co-ticarclav). (wikipedia.org)
  • However Timentin contains clavulanate unlike Ticar Ticarcillin/clavulanate: Timentin, in Australia, the UK, and the US, was marketed by Beecham, then GlaxoSmithKline. (wikipedia.org)
  • Available in India as TICANTROL (TICARCILLIN/ clavulanate) marketed by SCUTONIX LIFESCIENCES, Bombay Carbenicillin is used in the clinic primarily because of its low toxicity and its utility in treating urinary tract infections due to susceptible Pseudomonas species. (wikipedia.org)
  • Timentinâ„¢ is a 15:1 mixture of ticarcillin and clavulanate. (goldbio.com)
  • A 20 µL solution containing the antibiotic ticarcillin clavulanate is dissolved in heparinized (30 units/mL) 0.9% saline and flushed through the catheter immediately after implantation, daily throughout recovery, and before and after each self-administration session. (jax.org)
  • For example, penicillin-sensitive patients are highly likely to react to semisynthetic penicillins (eg, amoxicillin , carbenicillin, ticarcillin). (merckmanuals.com)
  • citation needed] Ticarcillin, like penicillin, contains a β-lactam ring that can be cleaved by beta-lactamases, resulting in inactivation of the antibiotic. (wikipedia.org)
  • Due, at least in part, to the common β-lactam ring, ticarcillin can cause reactions in patients allergic to penicillin. (wikipedia.org)
  • Ticarcillin is a penicillin ß-lactam antibiotic, which is susceptible to ß-lactamase degradation. (goldbio.com)
  • citation needed] In molecular biology, ticarcillin is used to as an alternative to ampicillin to test the uptake of marker genes into bacteria. (wikipedia.org)
  • Ticarcillin, symptoms of low blood pressure can include. (njacs.org)
  • Nous avons analysé les infections des plaies après un acte chirurgical chez 1200 patients blessés pendant le conflit libyen en 2011 et admis au service des urgences du centre médical de Tripoli. (who.int)
  • Les bacilles à Gram-négatif multirésistants représentaient un facteur de complication important pour les infections de plaies associées à des blessures de guerre chez des patients blessés en Libye. (who.int)
  • Ticarcillin has activity against most of the agents that are sensitive to natural penicillins, but is often less active. (nih.gov)
  • Rare instances of idiosyncratic, clinically apparent cholestatic liver injury have been reported in persons receiving ticarcillin in combination with clavulanate, some of which resemble the rare idiosyncratic reactions that can occur with many penicillins and which resemble the cholestatic liver injury that occurs after amoxicillin/clavulanate. (nih.gov)
  • Patients with ticarcillin induced hepatitis should avoid reexposure to other penicillins and should take cephalosporins with caution. (nih.gov)
  • Ticarcillin Disodium and Clavulanate Potassium for Injection is penicillins antibiotics used to treat severe infections inculding sepsis, bacteremia, peritonitis, intra-abdominal sepsis. (inopha.net)
  • We are China supplier of Ticarcillin Disodium and Clavulanate Potassium for Injection 1.6g & 3.2g. (inopha.net)
  • However Timentin contains clavulanate unlike Ticar Ticarcillin/clavulanate: Timentin, in Australia, the UK, and the US, was marketed by Beecham, then GlaxoSmithKline. (wikipedia.org)
  • It can be sold and used in combination with clavulanate as ticarcillin/clavulanic acid. (wikipedia.org)
  • Ticarcillin is also often paired with a β-lactamase inhibitor such as clavulanic acid (co-ticarclav). (wikipedia.org)
  • Given parenterally, ticarcillin-clavulanate can cause mild transient aminotransferase elevations, and therapy has been linked to instances of acute cholestatic liver disease similar to that described commonly with amoxicillin-clavulanate (Augmentin). (nih.gov)
  • The extended spectrum of ticarcillin made it an appropriate agent in therapy of Pseudomonas aeruginosa. (nih.gov)
  • Ticarcillin is an extended-spectrum carboxypenicillin antibiotic and is used to treat moderate-to-severe infections due to susceptible organisms. (nih.gov)
  • Intravenous ticarcillin therapy has been associated with mild and transient serum aminotransferase elevations that were generally self-limited and only slightly more common with ticarcillin than with comparative antibiotics. (nih.gov)
  • In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey. (nih.gov)
  • Ticarcillin is not absorbed orally, so must be given by intravenous or intramuscular injection. (wikipedia.org)
  • References to the safety and potential hepatotoxicity of ticarcillin are provided in the drug record on Ticarcillin-Clavulanate. (nih.gov)
  • Ticarcillin also has extended activity against some Enterobacter and Proteus species. (nih.gov)
  • Ticarcillin, the Ventolin price ranges from 49 to 55 depend. (njacs.org)